Introduction
============

Renal cell carcinoma (RCC) is the most common malignant tumor occurring from renal parenchyma, accounting for 3% of solid adult neoplasm.[@b1-rru-9-107] A unique feature of RCC is an intraluminal extension into renal venous circulation, a so-called tumor thrombus. Venous extension from the renal vein to the inferior vena cava (IVC) has been reported in 4%--10% of patients with RCC.[@b2-rru-9-107]--[@b4-rru-9-107] Approximately 20%--30% of patients with RCC are reported to have metastasis at the time of diagnosis and distant metastasis after surgical intervention for primary tumor.[@b1-rru-9-107],[@b4-rru-9-107] Although the majority of patients with distant metastasis have unfavorable prognosis, venous extension without metastasis has a more optimistic prognosis.[@b1-rru-9-107] Indeed, a 5-year cancer-specific survival in such patients is \~60%.[@b5-rru-9-107] In addition, recently, slight improvement in the prognosis of RCC patients with metastasis and venous extension by treatment with multi-targeted tyrosine kinase inhibitors (TKIs) has been reported.[@b1-rru-9-107] Therefore, surgical intervention for RCC patients with venous extension should be considered as an option. However, the difficulty of resection increases with the degree of venous extension, which in turn increases the risk of perioperative morbidity and mortality.[@b3-rru-9-107] Extended tumor thrombus into IVC above the hepatic vein is reported in \<1% of patients.[@b3-rru-9-107] The surgical procedure for such cases is technically complex.[@b3-rru-9-107]--[@b5-rru-9-107] In addition, clear cell RCC (ccRCC) shows extreme hypervascularity, which increases the potential for significant bleeding during surgery for large RCC with or without tumor thrombus due to the presence of well-developed collaterals.[@b6-rru-9-107] Therefore, early interception of arterial blood supply is a key procedure in nephrectomy; however, early clamping of renal artery may be difficult in some cases as a result of renal arteries located posterior to large hilar RCC, bulky lymphadenopathy, or thickened tumor thrombus.

In this report, we retrospectively reviewed our experience with two recent RCC cases with (internal) IVC extension and a case with direct (external) IVC invasion through adrenal gland. In the initial state of surgical intervention in these three cases, we performed successful early laparoscopic ligation of the renal artery. Our findings are reported in this paper.

Patients and methods
====================

Two RCC patients with venous extension to IVC and a case of RCC with direct invasion to IVC underwent radical nephrectomy at our hospital between July 2015 and January 2016. All patients received presurgical axitinib treatment according to the following protocol: All patients received 5 mg axitinib twice daily for 12--16 weeks. Objective response to treatment was assessed by computed tomography (CT) with enhancement at 4 and 12 weeks. Our protocol called for immediate surgical intervention if disease progression was observed at 4 weeks.[@b7-rru-9-107] The preoperative off-treatment period was 3--4 days. Patient characteristics, clinical stage, and baseline laboratory findings are shown in [Table 1](#t1-rru-9-107){ref-type="table"}. The performance status of each patient based on Eastern Cooperative Oncology Group criteria was 0 or 1. Tumor thrombus level was defined according to the classification established by Neves and Zinkcke.[@b8-rru-9-107] Treatment dose, period, and drug-related adverse events in presurgical axitinib therapy are shown in [Table 2](#t2-rru-9-107){ref-type="table"}. The complications that occurred intraoperatively are shown in [Table 3](#t3-rru-9-107){ref-type="table"}, and postoperative complications were recorded according to the Clavien--Dindo system.[@b9-rru-9-107]

No preoperative transcatheter arterial embolization (TAE) was performed in any of the three cases. During surgery, mobilization of the liver to expose the retrohepatic IVC and management of short hepatic veins as well as exfoliation between tumor and liver were performed by gastroenterological surgeons. Sternotomy and extracorporeal circulation with cardio-pulmonary bypass (CPB) were performed by cardiothoracic surgeons. Pathological result and prognosis are shown in [Table 4](#t4-rru-9-107){ref-type="table"}.

Patient 1
---------

A hypervasucular tumor affecting the right kidney measuring 10 cm in diameter with tumor thrombus was discovered incidentally in a 53-year-old male. Initial laboratory data were within normal limits. The tumor thrombus extended to IVC (level I) through two renal veins ([Figure 1A--C](#f1-rru-9-107){ref-type="fig"}). However, the ineffectiveness of presurgical treatment prompted the decision to recommend surgery. To prevent perioperative thromboembolism, the IVC filter was placed prior to surgery. The patient was placed in a lateral position, and the laparoscopic procedure employing a retroperitoneal approach was performed for ligating the right renal artery and right lumber veins. We could easily extend the retroperitoneal space, and the target artery was identified and dissected ([Figure 1E](#f1-rru-9-107){ref-type="fig"}). The IVC was also exposed, and the right lumber veins were dissected. During this procedure, the majority of the posterior surface of the kidney was easily isolated from the posterior abdominal wall. Next, the patient was repositioned to the supine position, and open surgical procedure was performed through inverted L incision to the upper abdomen. IVC and bilateral renal veins were exposed, and left lumbar veins and short hepatic veins were dissected. After clamping the caudal IVC, left renal vein, and cephalic IVC, the wall of IVC was cut, and the tumor thrombus with right kidney was removed. The patient recovered without perioperative complications and remained free of recurrence and metastasis for 5 months.

Patient 2
---------

A 63-year-old male was incidentally diagnosed with right renal tumor during the investigation of left inguinal hernia by CT. A hypervascular tumor measuring 10 cm in diameter, located at the upper pole of the kidney, was invading directly into the IVC wall through the adrenal gland ([Figure 2A--C](#f2-rru-9-107){ref-type="fig"}). Liver infiltration was also suspected. After 3 months of presurgical axitinib treatment, the tumor decreased in size, and the tumor border to liver appeared clearly. We initiated laparoscopic surgery in the patient in the customary lateral position and employed the transperitoneal approach, because of expected adhesion of tumor and IVC, liver, and posterior abdominal wall, which would increase the difficulty of kidney mobilization. After mobilizing the ascending, transverse colon and duodenum, we approached the renal artery from the caudal side by expanding the space between the lower pole of the kidney and IVC. The right renal artery was easily detected and ligated. We then ligated the renal veins. The caudal posterior section of the kidney was removed smoothly; however, because the tumor was strongly connected with IVC and liver at the cranial section, we converted to open surgery while maintaining the patient in the same position. Thoracoabdominal incision was made over the bed of the seventh rib and carried to the midline. As partial superficial (capsular) invasion was observed, the liver surface was partly resected. As the tumor invasion to IVC wall was grossly apparent, we performed side clamping to IVC and partially resected the tumor with IVC wall. However, injury of IVC during this procedure required repair of IVC wall by suturing (with blood transfusion). The tumor was partially connected with the diaphragm, thereby requiring repair after the removal of the right kidney. In spite of intraoperative bleeding with blood transfusion, the patient recovered without postoperative complications and has remained free of recurrence and metastasis for 6 months.

Patient 3
---------

A 61-year-old female presented to our hospital complaining of gross hematuria with palpable left flank mass. Initial laboratory data revealed severe anemia, hypercalcemia, and elevated CRP indicating poor risk according to Memorial Sloan Kettering Cancer Center criteria ([Table 1](#t1-rru-9-107){ref-type="table"}). The patient had hypervasucular tumor at the left kidney measuring 13 cm in diameter with long venous extension to the suprahepatic IVC ([Figure 3A](#f3-rru-9-107){ref-type="fig"}) and left gonadal vein ([Figure 3B](#f3-rru-9-107){ref-type="fig"}). In addition, metastases were observed in lungs and hilar lymph nodes ([Figure 3C and D](#f3-rru-9-107){ref-type="fig"}). Initially, indication of the nephrectomy was questionable; however, we confirmed that metastases were controllable by presurgical axitinib treatment. Therefore, we considered surgical intervention. After the patient was placed in the lateral position, we began the procedure by laparoscopy to mobilize the spleen, pancreas tail, and descending colon and ligate the left renal artery. Next, we adjusted the patient to the supine position, and open surgical intervention was performed through inverted T incision to the upper abdomen. IVC and bilateral renal veins were exposed, and the liver was mobilized to expose retrohepatic IVC. As the tumor extension in this case advanced to level III, IVC was secured under the diaphragm, and Pringle maneuver was performed. Under clamping of the right renal vein, hepatoduodenal ligament and IVC (under diaphragm and caudal part to the termination of the right renal vein), a small incision was performed to the anterior surface of IVC; however, we encountered uncontrollable bleeding. Accordingly, we closed the IVC scar, and de-clamped (clamping time was 5 minutes). The segmental resection of infrahepatic IVC is necessary, which, however, would significantly increase the difficulty of reconstruction following removal. For this reason, we performed CPB with deep hypothermic circulatory arrest (DHCA). We performed midline sternotomy in preparation for cannulation to superior vena cava (SVC) and left ventricles to establish CPB and to commence active cooling toward 20°C. After initiation of DHCA, IVC was segmentally dissected along with tumor thrombus. Tumor thrombus was covered by latex material and carefully removed by passing it under the superior mesenchymal artery. The left kidney was then extracted completely. The reconstruction of IVC was accomplished with bovine pericardium patch. CPB was reinstituted and re-warming was started. Once normothermia was achieved, the patient was weaned from CPB and decannulated. After ensuring hemostasis, operative scars were closed in ordinary fashion. On the second day post-surgery, the patient complained of dyspnea, which was caused by increased pleural effusion from metastasis. We inserted a drainage tube, which improved the patient's condition. The TKI treatment was initiated 1 month after surgery and has maintained stable disease for 3 months.

Discussion
==========

Surgical intervention in the treatment of locally advanced RCC may be controversial. Severe mortality (6.3%--10.5%) is reported in high-level venous extension. In addition, major perioperative complications are reported in 20%--30% of patients with levels 0--II venous extension and 34%--74% of patients with levels III---IV.[@b10-rru-9-107] However, approximately 60% of RCC patients with venous extension without metastasis respond well to complete removal of tumor with thrombus,[@b5-rru-9-107] and complete excision with en bloc resection of involved structures, such as IVC wall for large (T4) tumor, may provide a cure. To date, several controversial points regarding the treatment of such cases have been reported. These include the following: 1) control of arterial blood supply in the early phase; 2) liver mobilization technique (collaboration with gastrointestinal surgeon); 3) indication and procedures of CPB with DHCA (collaboration with cardiothoracic surgeon); and 4) indication of cytoreductive nephrectomy for M1 cases. In addition, a well-considered plan created in collaboration with gastroenterological and cardiothoracic surgeons to ensure the inclusion of integrated intraoperative expertise is required to promote successful outcomes.

The advantage of preoperative TAE of renal artery for controlling arterial blood supply has been debated.[@b11-rru-9-107]--[@b14-rru-9-107] On the other hand, disadvantages include the risk of pulmonary embolization by necrotic tumor thrombus and postinfarction syndrome with fever and pain.[@b11-rru-9-107] Ciancio et al reported intraoperative early ligation of right renal artery by "posterior approach," in which the renal artery was ligated after internal mobilization of kidney.[@b12-rru-9-107] The current approach using laparoscopic surgical procedures achieved the same outcome as TAE and posterior approach in open surgery without risk of TAE-related complication and mobilization of the kidney. In addition, this approach can be performed in a narrow space, in bilateral cases and on various sized tumors. As shown in patient 1, retroperitoneal approach was very useful for ligation of the right renal artery and lumber veins. Retroperitoneal or transperitoneal laparoscopic nephrectomy combined with open thrombectomy have been reported.[@b13-rru-9-107],[@b14-rru-9-107] In these reports, advantages of laparoscopic approach for procedures in the deep area in the preliminary stage of operation include easier isolation of kidney, ligation of renal artery, isolation of IVC, mobilization of peritoneal organs, positioning of the vessel loop, and dissection of ureter, whereas most delicate procedures such as mobilizing the liver, cutting IVC, removing tumor thrombus, and suturing IVC are suitable for open surgery.[@b13-rru-9-107],[@b14-rru-9-107] In addition, if retroperitoneal approach is possible, this procedure affords easier access to renal artery and IVC than transperitoneal approach because there is no need to mobilize liver, colon, and duodenum in the initial step.[@b13-rru-9-107],[@b14-rru-9-107] In our series, laparoscopic early ligation of renal artery was successfully performed in all cases, by retroperitoneal approach in patient 1, transperitoneal approach in patient 2 (because mobilization of kidney was impossible), and patient 3 (left RCC with IVC thrombus); and there was no significant perioperative complication with this procedure. Therefore, laparoscopic approach in the early stage of the procedure for cT3b-c-staged RCC may be an option for the control of bleeding. However, evaluation of the potential perioperative outcome advantages of this procedure will require a greater number of cases.

Although the significance of cytoreductive nephrectomy in metastatic RCC (mRCC) is reported, that of surgical intervention in cases with venous extension is still controversial because of the high perioperative complication and mortality rates.[@b15-rru-9-107] Kwon et al retrospectively analyzed 45 mRCC patients with venous extension.[@b1-rru-9-107] This study showed that local control may have benefits for survival in the selected cases. In the present case (patient 3), our surgical team thoroughly discussed the indication of surgical intervention considering risks and benefits. Because favorable control for primary and metastatic sites was observed by presurgical treatment ([Figure 3B and C](#f3-rru-9-107){ref-type="fig"}), we decided that intervention would be appropriate. Although the patient developed dyspnea postoperatively due to increased pleural effusion from metastasis, she recovered after temporary drainage of the thoracic space, and the TKI treatment started smoothly.

We successfully performed nephrectomy combined with laparoscopic and open surgery in three cases of RCC with IVC extension. The advantages of laparoscopic procedure are that it facilitates early ligation of the renal artery and that it allows ease of access to the deep narrow space encountered in various types (size and shape) of renal tumor.

Indication of surgical intervention for mRCC with IVC thrombus remains controversial; however, cytoreductive nephrectomy may be beneficial in some cases when appropriate targeted therapy is initiated immediately after surgery. The current case recovered successfully from the perioperative state; however, careful follow-up is required.

Consent
=======

Written consent to publish the case details has been provided by the first and second patients in this case series. However, the third patient has since passed away and the authors were unable to contact the next of kin despite exhaustive attempts, therefore the case details have been sufficiently anonymized so that no harm is caused to the patient or their family, the Ethics Committee of Miyazaki University has approved publication of the case details in this instance.
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![Computed tomography (CT) findings (**A**--**C**), resected specimen (**D**), and intraoperative laparoscopic findings (**E**) in Patient 1.\
**Notes:** Hypervascular renal tumor (**A**) with IVC extension through cranial side renal vein (**B**) and caudal side of renal vein (**C**). Macroscopic appearance of the specimen is shown (**D**). Arrowhead indicates the tip of tumor thrombus in each renal veins. Laparoscopic appearance in retroperitoneal approach (**E**) shows IVC and renal artery (arrowhead, left) and dissected lumber vein (arrowhead, right).\
**Abbreviation:** IVC, inferior vena cava.](rru-9-107Fig1){#f1-rru-9-107}

![Computed tomography (CT) findings (**A** and **B**) and resected specimen (**C**) in Patient 2.\
**Notes:** Right renal tumor directly invaded to ipsilateral adrenal gland (**A** and **B**). Arrowhead indicates cranial border with liver (left) and IVC (right). Surgical specimens are cut longitudinally (**C**). Yellow-colored tumor is observed at the upper pole of the kidney and adrenal invasion can be seen (arrowheads).](rru-9-107Fig2){#f2-rru-9-107}

![Computed tomography (CT) appearance in Patient 3.\
**Notes:** Left renal tumor extended to IVC (**A**) and gonadal veins (**B**). Metastasis of lung (**C**) was reduced after presurgical treatment (**D**). Arrowheads indicate the tip of the tumor thrombus.](rru-9-107Fig3){#f3-rru-9-107}

###### 

Clinical characteristics of patients

  Patient   Age   Sex   Laterality   PS   Thrombus level   Clinical stage      Laboratory data                                           
  --------- ----- ----- ------------ ---- ---------------- ------------------- ----------------- ---------- ------ ------ ----- -------- --------
  1         53    M     R            0    1                3b                  0                 6          4.43   9.6    218   16.9     0.97
  2         63    M     R            0    --               4 (adrenal gland)   0                 0          3.74   9 1    149   13\. 6   1\. 69
  3         61    F     L            1    III              3b                  0                 1 (lung)   2.67   10.5   368   6.9      15\. 5

**Abbreviations:** PS, Eastern Cooperative Oncology Group performance status; Alb, albumin; Ca, calcium; LDH, lactate dehydrogenase; Hb, hemoglobin; CRP, C-reactive protein.

###### 

Progress of presurgical treatment and drug-related adverse events

  -----------------------------------------------------------------------------------------------------------------
  Patient   Treatment dose (BID)   Adverse events   Treatment period (days)        Off-treatment penod (days)   
  --------- ---------------------- ---------------- ------------------------------ ---------------------------- ---
  1         5                      5                Hypertension G2                81                           4

  2         5                      3                Hypertension G2\               92                           3
                                                    Hypothyroidism G2\                                          
                                                    Fatigue, Loss of appetite G2                                

  3         6                      5                Hypertension G2                120                          3
  -----------------------------------------------------------------------------------------------------------------

**Abbreviations:** Max, maximum dose; Min, minimum dose; G, grade.

###### 

Operative records and perioperative complications

  Patient   Operation time   Bleeding   Complications                       
  --------- ---------------- ---------- --------------- ------------------- -------------------------
  1         494              94         550             --                  --
  2         404              145        4,030           Blood transfusion   --
  3         595              161        1,220           --                  Pleural effusion (Illa)

###### 

Pathological result and prognosis

  Patient   Histopalhological features   Prognosis                                                               
  --------- ---------------------------- ----------- ---- ---- ------------------------------------------------- --------------------
  1         Clear cell                   2           20   5    Alive without disease                             --
  2         Clear cell                   2\>3        70   11   Alive with contralateral adrenal metastases (7)   Metastasctomy
  3         Clear cell                   2           80   5    Alive with bone metastasis (4)                    Radiation with TKI

**Abbreviation:** TKI, tyrosine kinase inhibitors.
